5AM Ventures V, L.P. has bought stock on 3 days since Oct 2019
10% owner at Entrada Therapeutics, Inc., and 3 other companies
SEC CIK 0001674324 · Filings on SEC.gov ↗
5AM Ventures V, L.P.'s record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Companies
Every filing
10 filings since Oct 2019, newest first
Entrada Therapeutics, Inc.
10% owner
Entrada Therapeutics, Inc.
10% owner
Entrada Therapeutics, Inc.
10% owner
Cabaletta Bio, Inc.
10% owner
Cabaletta Bio, Inc.
10% owner
Impel Neuropharma Inc
10% owner
Cabaletta Bio, Inc.
10% owner
Akouos, Inc.
10% owner
Cabaletta Bio, Inc.
10% owner
Cabaletta Bio, Inc.
10% owner
About 5AM Ventures V, L.P.
5AM Ventures V, L.P. is a company and life sciences venture capital fund associated with 5AM Ventures, a firm founded in 2002 that focuses on investing in and building next-generation life science companies.( 5AM Ventures V was the firm’s fifth fund, raised in 2016 with $285 million in commitments, and 5AM has since expanded into later-stage investing through additional vehicles, including a 2022 close of $750 million across 5AM Ventures VII and 5AM Opportunities II.(
The fund is part of a venture platform that invests primarily in early-stage therapeutics, drug delivery, diagnostics, and related life science technologies, with a hands-on approach to portfolio company development.( SEC filings identify 5AM Partners V, LLC as the sole general partner of 5AM Ventures V, L.P., indicating that the fund is managed through the broader 5AM Ventures organization rather than as an operating company with separate executive leadership.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.